TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)

Clinical trial NCT07668869 · RECRUITING

Trial details

NCT number: NCT07668869
Sponsor: Prof. Franciszek Lukaszczyk Memorial Oncology Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Glioblastoma Multiforme, Adult

Start date: 2025-12-30
Primary completion: 2030-06-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.